|
1
|
Boyle P and Langman JS: ABC of colorectal
cancer: Epidemiology. BMJ. 321:805–808. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J,
Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin.
58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Walsh JM and Terdiman JP: Colorectal
cancer screening: Scientific review. JAMA. 289:1288–1296. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kang H, O'Connell JB, Maggard MA, Sack J
and Ko CY: A 10-year outcomes evaluation of mucinous and
signet-ring cell carcinoma of the colon and rectum. Dis Colon
Rectum. 48:1161–1168. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cunningham D, Atkin W, Lenz HJ, Lynch HT,
Minsky B, Nordlinger B and Starling N: Colorectal cancer. Lancet.
375:1030–1047. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bagga S, Bracht J, Hunter S, Massirer K,
Holtz J, Eachus R and Pasquinelli AE: Regulation by let-7 and lin-4
miRNAs results in target mRNA degradation. Cell. 122:553–563. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
White NM, Bao TT, Grigull J, Youssef YM,
Girgis A, Diamandis M, Fatoohi E, Metias M, Honey RJ, Stewart R, et
al: miRNA profiling for clear cell renal cell carcinoma: Biomarker
discovery and identification of potential controls and consequences
of miRNA dysregulation. J Urol. 186:1077–1083. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nelson KM and Weiss GJ: MicroRNAs and
cancer: Past, present, and potential future. Mol Cancer Ther.
7:3655–3660. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Osanto S, Qin Y, Buermans HP, Berkers J,
Lerut E, Goeman JJ and van Poppel H: Genome-wide microRNA
expression analysis of clear cell renal cell carcinoma by next
generation deep sequencing. PLoS One. 7:e382982012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hwang HW and Mendell JT: MicroRNAs in cell
proliferation, cell death, and tumorigenesis. Br J Cancer. 96
Suppl:R40–R44. 2007.PubMed/NCBI
|
|
13
|
Li C, Xu N, Li YQ, Wang Y and Zhu ZT:
Inhibition of SW620 human colon cancer cells by upregulating
miRNA-145. World J Gastroenterol. 22:2771–2778. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li B, Song Y, Liu TJ, Cui YB, Jiang Y, Xie
ZS and Xie SL: miRNA-22 suppresses colon cancer cell migration and
invasion by inhibiting the expression of T-cell lymphoma invasion
and metastasis 1 and matrix metalloproteinases 2 and 9. Oncol Rep.
29:1932–1938. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ahmed FE: miRNA as markers for the
diagnostic screening of colon cancer. Expert Rev Anticancer Ther.
14:463–485. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Finnerty JR, Wang WX, Hébert SS, Wilfred
BR, Mao G and Nelson PT: The miR-15/107 group of microRNA genes:
Evolutionary biology, cellular functions, and roles in human
diseases. J Mol Biol. 402:491–509. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pan Y, Chen Y, Ma D, Ji Z, Cao F, Chen Z,
Ning Y and Bai C: miR-646 is a key negative regulator of EGFR
pathway in lung cancer. Exp Lung Res. 42:286–295. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li W, Liu M, Feng Y, Xu YF, Huang YF, Che
JP, Wang GC, Yao XD and Zheng JH: Downregulated miR-646 in clear
cell renal carcinoma correlated with tumour metastasis by targeting
the nin one binding protein (NOB1). Br J Cancer. 111:1188–1200.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Venkatachalam R, Verwiel ET, Kamping EJ,
Hoenselaar E, Görgens H, Schackert HK, van Krieken JH, Ligtenberg
MJ, Hoogerbrugge N, van Kessel AG and Kuiper RP: Identification of
candidate predisposing copy number variants in familial and
early-onset colorectal cancer patients. Int J Cancer.
129:1635–1642. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Slattery ML, Wolff E, Hoffman MD, Pellatt
DF, Milash B and Wolff RK: MicroRNAs and colon and rectal cancer:
Differential expression by tumor location and subtype. Genes
Chromosomes Cancer. 50:196–206. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tone Y, Tanahashi N, Tanaka K, Fujimuro M,
Yokosawa H and Toh-e A: Nob1p, a new essential protein, associates
with the 26S proteasome of growing saccharomyces cerevisiae cells.
Gene. 243:37–45. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wild T, Horvath P, Wyler E, Widmann B,
Badertscher L, Zemp I, Kozak K, Csucs G, Lund E and Kutay U: A
protein inventory of human ribosome biogenesis reveals an essential
function of exportin 5 in 60S subunit export. PLoS Biol.
8:e10005222010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wyler E, Zimmermann M, Widmann B, Gstaiger
M, Pfannstiel J, Kutay U and Zemp I: Tandem affinity purification
combined with inducible shRNA expression as a tool to study the
maturation of macromolecular assemblies. RNA. 17:189–200. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu Y, Huang H, Yuan B, Zhuang LY, Luo TP
and Zhang Q: Lentivirus-mediated knockdown of NOB1 suppresses the
proliferation of colon cancer cells. Z Gastroenterol. 52:429–435.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu K, Chen HL, Gu MM and You QS:
Relationship between NOB1 expression and prognosis of resected
non-small cell lung cancer. Int J Biol Markers. 30:e43–e48. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang X, Zhang D, Qu F, Hong Y, Cao J, Pan
X, Li L, Huang Y, Huang H, Yin L, et al: Knockdown of NOB1
expression inhibits the malignant transformation of human prostate
cancer cells. Mol Cell Biochem. 396:1–8. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Veith T, Martin R, Wurm JP, Weis BL,
Duchardt-Ferner E, Safferthal C, Hennig R, Mirus O, Bohnsack MT,
Wöhnert J and Schleiff E: Structural and functional analysis of the
archaeal endonuclease Nob1. Nucleic Acids Res. 40:3259–3274. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lin Y, Peng S, Yu H, Teng H and Cui M:
RNAi-mediated downregulation of NOB1 suppresses the growth and
colony-formation ability of human ovarian cancer cells. Med Oncol.
29:311–317. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lin S, Meng W, Zhang W, Liu J, Wang P, Xue
S and Chen G: Expression of the NOB1 gene and its clinical
significance in papillary thyroid carcinoma. J Int Med Res.
41:568–572. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
He XW, Feng T, Yin QL, Jian YW and Liu T:
NOB1 is essential for the survival of RKO colorectal cancer cells.
World J Gastroenterol. 21:868–877. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang W, Zhong W, Xu J, Su B, Huang G, Du
J and Liu Q: Lentivirus-mediated gene silencing of NOB1 suppresses
non-small cell lung cancer cell proliferation. Oncol Rep.
34:1510–1516. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Moyer MP, Manzano LA, Merriman RL,
Stauffer JS and Tanzer LR: NCM460, a normal human colon mucosal
epithelial cell line. In Vitro Cell Dev Biol Anim. 32:315–317.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang P, Zuo Z, Wu A, Shang W, Bi R, Jin
Q, Wu J and Jiang L: miR-600 inhibits cell proliferation, migration
and invasion by targeting p53 in mutant p53-expressing human
colorectal cancer cell lines. Oncol Lett. 13:1789–1796.
2017.PubMed/NCBI
|
|
34
|
Wang Q, Zhu L, Jiang Y, Xu J, Wang F and
He Z: miR-219-5p suppresses the proliferation and invasion of
colorectal cancer cells by targeting calcyphosin. Oncol Lett.
13:1319–1324. 2017.PubMed/NCBI
|
|
35
|
Sheng N, Tan G, You W, Chen H, Gong J,
Chen D, Zhang H and Wang Z: MiR-145 inhibits human colorectal
cancer cell migration and invasion via PAK4-dependent pathway.
Cancer Med. 6:1331–1340. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ding L, Yu LL, Han N and Zhang BT: miR-141
promotes colon cancer cell proliferation by inhibiting MAP2K4.
Oncol Lett. 13:1665–1671. 2017.PubMed/NCBI
|
|
37
|
Liu Y, Liu R, Yang F, Cheng R, Chen X, Cui
S, Gu Y, Sun W, You C, Liu Z, et al: miR-19a promotes colorectal
cancer proliferation and migration by targeting TIA1. Mol Cancer.
16:532017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lu D, Yao Q, Zhan C, Le-Meng Z, Liu H, Cai
Y, Tu C, Li X, Zou Y and Zhang S: MicroRNA-146a promote cell
migration and invasion in human colorectal cancer via
carboxypeptidase M/src-FAK pathway. Oncotarget. 8:22674–22684.
2017.PubMed/NCBI
|
|
39
|
Zhou J, Xu T, Yan Y, Qin R, Wang H, Zhang
X, Huang Y, Wang Y, Lu Y, Fu D and Chen J: MicroRNA-326 functions
as a tumor suppressor in glioma by targeting the Nin one binding
protein (NOB1). PLoS One. 8:e684692013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Huang P, Xi J and Liu S: MiR-139-3p
induces cell apoptosis and inhibits metastasis of cervical cancer
by targeting NOB1. Biomed Pharmacother. 83:850–856. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ji S, Zhang B, Kong Y, Ma F and Hua Y:
MiR-326 inhibits gastric cancer cell growth through down regulating
NOB1. Oncol Res. 25:853–861. 2017. View Article : Google Scholar : PubMed/NCBI
|
